Cas No.: | 37318-06-2 |
Synonyms: | Gopalamicin;Salbomycin;Azalomycin B |
SMILES: | CC[C@@H]1[C@@H](C)O[C@]([C@H]([C@@H]([C@@H]([C@H]2OC(=O)C=CC=C[C@H](C)[C@@H]([C@H]([C@H]([C@@H]([C@@]3(O[C@H](C)[C@@H](CC)[C@H](O[C@H]4C[C@H](O)[C@H](O)[C@H](C)O4)C3)O)C)O)C)OC(=O)C=CC=C[C@@H]2C)C)O)C)(O)C[C@H]1O[C@H]1C[C@H](O)[C@H](O)[C@H](C)O1 |c:54,t:14,16,52,&1:2,3,6,7,8,9,10,18,20,21,22,23,24,26,28,31,33,35,37,39,54,61,63,65,67,69| |
Formula: | C54H88O18 |
M.Wt: | 1025.3 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Elaiophylin (Gopalamicin;Salbomycin;Azalomycin B) is a macrodiolide antibiotic that shows in vitro anti-protozoal activity against both Plasmodium and Trypanosoma (IC50=370 and 460 ng/ml, respectively) and cytotoxicity against human fetal lung fibroblast MRC-5 cells (IC50=870 ng/ml); also is a novel autophagy inhibitor that promotes autophagosome accumulation but blocks autophagic flux by attenuating lysosomal cathepsin activity, resulting in the accumulation of SQSTM1/p62 in various cell lines. |